IP Library › Assignment 027401/0722
Patent Assignment
Reel/Frame 027401/0722

Change of Name

Recorded: 2011-12-16 Pages: 4
Assignor
AXCAN PHARMA INC.
Executed: 2011-09-08
Assignee
APTALIS PHARMA CANADA INC.
597 LAURIER BOULEVARD, MONT-SAINT-HILAIRE, QUEBEC, J3H 6C4, CANADA
Covered Properties (3)
Mesalamine Suppository
Patent: 7,541,384 →
Application: 12/245,648 →
Publication: US 2009/0022793
Mesalamine Suppository
Patent: 8,217,083 →
Application: 12/476,185 →
Publication: US 2009/0264386
Mesalamine Suppository
Patent: 8,436,051 →
Application: 12/639,645 →
Publication: US 2010/0105639
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 17, 2009
From: GAUTHIER, CARL; DUMOULIN, YVES; POWELL, DAVID; MOREAU, HUGUES
To: AXCAN PHARMA INC.
Reel/Frame 023670/0156 →
Change of Name Dec 13, 2011
From: AXCAN PHARMA INC.
To: AXCAN PHARMA CANADA INC.
Reel/Frame 027373/0622 →
Patent Security Agreement Oct 31, 2013
From: APTALIS PHARMA CANADA INC.; APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031531/0488 →
Termination and Release Jan 31, 2014
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: APTALIS PHARMA US, INC.; APTALIS PHARMATECH, INC.; APTALIS PHARMA CANADA INC.
Reel/Frame 032149/0111 →
Change of Name Mar 18, 2016
From: APTALIS PHARMA CANADA INC.
To: APTALIS PHARMA CANADA ULC
Reel/Frame 038037/0424 →